Status:
UNKNOWN
Lactulose for the Prevention of Nosocomial Infections in Children
Lead Sponsor:
Bnai Zion Medical Center
Conditions:
Nosocomial Infection
Eligibility:
All Genders
2-36 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the ability of lactulose, a prebiotic agent, to prevent hospital acquired infection in children
Detailed Description
Despite the adoption of norms regarding enteric isolation, nosocomial infectious diarrhea is common in children(1;2). Viral pathogens, especially rotavirus are responsible for most of the cases. Depen...
Eligibility Criteria
Inclusion
- All children aged 2 to 36 months who are admitted to the hospital for reasons other than diarrhea will be eligible for the study.
Exclusion
- Children with a history of probiotics or prebiotics use within 7 days before admission, acute gastroenteritis within 3 days before admission, vomiting, treated chronic constipation, known anatomic problem in the gastrointestinal tract will be excluded from the study.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00273949
Start Date
January 1 2006
End Date
January 1 2007
Last Update
February 6 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Department, Bnai Zion Medical Center
Haifa, Israel, 31048